Noida‑based Alphadroid raises INR 36 crore ($3.8 Mn) in pre‑Series A funding led by Alkemi Growth Capital to expand its robotics portfolio across healthcare, logistics, and warehousing.
Alphadroid secures $3.8 Mn in pre‑Series A round
Noida‑based robotics startup Alphadroid has raised INR 36 crore (approximately $3.8 million) in its pre‑Series A funding round, led by Alkemi Growth Capital. The round also includes participation from Shree Vasu Logistics Limited (SVLL) and a group of undisclosed high‑net‑worth individuals (HNIs). The fresh capital will help the company expand its product portfolio, strengthen its engineering and R&D teams, and scale operations across healthcare, logistics, and warehousing automation.
Founded in 2023 by Sanjeev Kumar, Alphadroid began its journey as an incubatee at IIIT Lucknow, where it developed its core robotics and AI‑driven automation capabilities. Since then, the startup has positioned itself as a full‑stack automation partner, building integrated systems that combine robotics, artificial intelligence, and software‑driven workflows for diverse sectors.
From incubation to industrial‑scale robots
Alphadroid designs and deploys integrated automation systems that reduce manual workload while improving operational efficiency in healthcare, hospitality, retail, and public infrastructure. Its robots act as intelligent agents that move materials, coordinate with backend systems, and adapt to dynamic environments, enabling organisations to handle high‑volume operations with fewer human‑intensive tasks.
The startup’s current product portfolio comprises five different types of robots capable of handling payloads ranging from 40 kg to 250 kg. These robots can integrate with lifts, existing enterprise systems, or third‑party software, enabling end‑to‑end automated workflows for material movement, inventory handling, and intra‑facility transport.
Subscription‑based model and sector focus
Alphadroid currently offers its robot services through a subscription‑based model, allowing clients to access automation without large upfront capital expenditure. This approach lowers the barrier to adoption for mid‑size and emerging‑growth organisations, which can trial and scale robotics solutions as their operational needs evolve.
Going forward, the company plans to acquire new clients, deepen its engineering and R&D capabilities, and build specialised automation solutions for the healthcare sector. Healthcare remains a primary focus area, where hospitals, diagnostic chains, and medical logistics operations often face bottlenecks in internal transport, inventory management, and sterilisation‑kit movement. Alphadroid aims to automate these workflows with AI‑enabled robots that operate 24/7, improving reliability and reducing human error.
Expansion into logistics and warehousing
Beyond healthcare, logistics and warehousing automation represent a natural growth path for Alphadroid. Both sectors operate at large scale, handle high‑volume throughput, and depend heavily on consistent, error‑free operations. By deploying robots that move goods, assist in sorting, and synchronise with warehouse‑management systems, the startup can help logistics and e‑commerce players improve turnaround time and labour productivity.
Sanjeev Kumar, Founder and CEO of Alphadroid, emphasised that the company is not merely adding AI and robotics as tools, but is building an automation ecosystem that shapes how industries evolve. “Healthcare remains a key focus, while logistics is a natural extension for us,” he said. “Both sectors operate at scale and require consistent efficiency, which is where we see the strongest role for automation. We are not just using AI and robotics as tools to transform operations, but creating an ecosystem that enables how industries evolve for the future.”
Why Alkemi Growth Capital backed Alphadroid
Alkemi Growth Capital, which led the pre‑Series A round, has a strong track‑record of investing in healthcare, consumer wellness, diagnostics, medtech, pharma, and health‑AI deep‑tech companies. Its portfolio includes well‑known startups such as Redcliffe Labs, Farmley, PeeSafe, and Doceree, all of which are reshaping India’s health‑tech ecosystem.
Commenting on the investment, Alka Goel, Partner at Alkemi Growth Capital, highlighted Alphadroid’s clear problem‑statement and execution focus. “What stood out to us about Alphadroid is not just the technology, but the clarity of the problem they are solving,” she said. “Healthcare systems today are constrained not by clinical expertise, but by operational inefficiencies that dilute the impact of that expertise.”
Goel added that Alphadroid’s approach to physical AI – using robots that perform real‑world tasks in live environments – directly addresses this operational gap. “They are not building for experimentation; they are building for deployment, and that distinction is critical,” she said. “We see this as a category‑defining opportunity within healthcare automation.”
Long‑term vision: an automation‑first future
With the new funding, Alphadroid aims to accelerate product development, refine its AI‑driven navigation and task‑planning algorithms, and expand its field‑engineering and customer‑support teams. The company also plans to invest in specialised vertical‑specific solutions, such as hospital‑bed‑transport robots, pharmacy‑delivery bots, and warehouse‑logistics robots that can interface with enterprise‑resource‑planning platforms.
By embedding intelligent automation into core workflows, Alphadroid seeks to create a future where manual, repetitive, and high‑risk tasks are handled by robots, while human workers focus on higher‑value, decision‑driven roles. As India’s logistics, warehousing, and healthcare sectors continue to scale, Alphadroid positions its robotics‑plus‑AI platform to become a foundational layer of operational efficiency and industrial modernisation.
Disclaimer
The information in this article is based on available public sources and official statements as of the time of publication. While we aim for accuracy, we do not guarantee completeness or correctness. We advise readers to verify key details from official sources before making any decisions. The website (iitiimsamvaad.com) is not liable for any loss or damage arising from the use of this content. The authors are also not responsible for any such loss or damage.